First combined COVID-19 and influenza vaccine for people 50 years and older

EMA has recommended granting a marketing authorisation in the European Union (EU) for mCombriax, a messenger RNA vaccine for protecting people aged 50 years and older against COVID-19 and seasonal influenza (flu).

COVID-19 and influenza are…